SVB Leerink Maintains Outperform on Surgery Partners, Raises Price Target to $65

SVB Leerink analyst Whit Mayo maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and raises the price target from $63 to $65.

SVB Leerink analyst Whit Mayo maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and raises the price target from $63 to $65.

Total
0
Shares
Related Posts